[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,158 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-05-20 | Class II | Integra LifeSciences Corp. (NeuroSciences)Z-2173-2026 | Out-of-specification endotoxin result that did not meet the acceptance criteria. | Environmental Monitoring |
| 2026-05-20 | Class II | GE Medical Systems, LLCZ-2152-2026 | GE HealthCare has become aware of a potential security vulnerability impacting AW Server deployed via Edison Health Link (EHL) based CT Smart Subscription used in conjunction with certain Revolution Apex, Revolution Ascend, and Revolution CT systems. | Data Integrity |
| 2026-05-20 | Class II | Hologic, IncZ-2168-2026 | Complaints have been received of systems developing loose, missing, or broken internal bolts over time. | — |
| 2026-05-20 | Class II | DJO, LLCZ-2135-2026 | Due to broken connector which may result in a temporary interruption of prescribed cold therapy. | — |
| 2026-05-20 | Class I | Medline Industries, LPZ-2139-2026 | Medline has identified the presence of particulate within the fluid path of the Manifolds. | Environmental Monitoring |
| 2026-05-13 | Class II | Erbe Medical, LLCZ-2062-2026 | Devices providing sterile water/CO2/air to endoscopes were manufactured with a distal irrigation segment connector configuration that may be more susceptible to unintended water flow from distal tip under unsupported third-party connector use conditions, which may lead to water aspiration, which may progress to aspiration pneumonia, acute respiratory distress syndrome, or respiratory failure. | Environmental Monitoring |
| 2026-05-13 | Class I | AVID Medical, Inc.Z-1974-2026 | Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. | — |
| 2026-05-13 | Class II | Katalyst Surgical, LLCZ-2071-2026 | Field Safety Corrective Action for IFU in DEX Forceps and Scissors. | Risk Management & CAPA |
| 2026-05-13 | Class II | Orthorebirth Co LtdZ-2132-2026 | Resorbable bone void filler falls outside standard specifications. | — |
| 2026-05-13 | Class II | Katalyst Surgical, LLCZ-2074-2026 | Field Safety Corrective Action for IFU in DEX Forceps and Scissors. | Risk Management & CAPA |
| 2026-05-13 | Class II | DFI Co., Ltd.Z-2085-2026 | The devices were distributed without required FDA premarket clearance or approval. | Documentation & Change Control |
| 2026-05-13 | Class I | AVID Medical, Inc.Z-1970-2026 | Potential risk for Medline syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold. | — |
| 2026-05-13 | Class II | DFI Co., Ltd.Z-2088-2026 | The devices were distributed without required FDA premarket clearance or approval. | Documentation & Change Control |
| 2026-05-13 | Class II | Medline Industries, LPZ-2113-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | Medline Industries, LPZ-2107-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | DFI Co., Ltd.Z-2084-2026 | The devices were distributed without required FDA premarket clearance or approval. | Documentation & Change Control |
| 2026-05-13 | Class II | Medline Industries, LPZ-2105-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | Orthorebirth Co LtdZ-2131-2026 | Resorbable bone void filler falls outside standard specifications. | — |
| 2026-05-13 | Class II | Medline Industries, LPZ-2110-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | Medline Industries, LPZ-2129-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | Intuitive Surgical, Inc.Z-2046-2026 | Due to manipulator containing screws with in the arm sub-assembly that my be susceptible to breaking. | — |
| 2026-05-13 | Class II | Medline Industries, LPZ-2126-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | Medline Industries, LPZ-2118-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
| 2026-05-13 | Class II | DFI Co., Ltd.Z-2082-2026 | The devices were distributed without required FDA premarket clearance or approval. | Documentation & Change Control |
| 2026-05-13 | Class II | Medline Industries, LPZ-2103-2026 | Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products. | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.